Carri is Partner at Karaktero. She brings over a decade of Lifescience capital markets expertise in biopharma. Prior to Karaktero, Carri worked on the Buyside, Sellside, and in IR at leading multinational companies. Capital markets experience includes serving as Senior Investor Relations Manager at Bayer and Senior Equity Analyst at Macquarie. As a consultant at Egon Zehnder, Carri worked with the C-suite and senior leaders at Biotech and Pharma companies. While Equity Analyst at Credit Suisse, she established the first buyside coverage of the Biotech sector. Currently, she advises companies on Corporate Finance and Communications and also mentors startups in Lifescience.
Carri received a premed Bachelors degree, a M.S in Plant Genetics at the US-Dept of Energy PRL at MSU and a PhD in Neuroscience from the ETH in Zurich.